Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stellate Ganglion Block for Postoperative Delirium in Older Adults
NCT07848113Not yet recruiting
- Sponsor
- Assiut University
- Start
- Oct 2026
- Primary completion
- Oct 2027
01
Overview
Randomised, open-label trial of ropivacaine in postoperative delirium (POD) (2 arms), sponsored by Assiut University. Primary endpoint: Cumulative incidence of postoperative delirium at 72 hours. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
ropivacaine
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on NCT07848113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07848113.